Fair-Value Report — AviChina Industry & Technology (2357.HK)

Verified Snapshot

Sources consulted: AAStocks (阿斯達克) DI and quote pages, stockanalysis.com, 10jqka (同花顺) F10, Sina Finance, Tencent/Sohu/Caizhongshe news coverage of the 2026 interim results, Eastmoney. Chinese-language primary sources used for all AviChina and subsidiary financial figures per house methodology; English aggregators used only as cross-checks (one, Yahoo-sourced, showed a stale P/B of 0.92x — superseded here by a primary-source recalculation).

Business

AviChina is the Hong Kong–listed holding and operating platform for the civil/dual-use aviation manufacturing businesses of AVIC (Aviation Industry Corporation of China), China's state aerospace and defense group, which holds ~57–60% of AviChina directly and indirectly. AviChina itself directly controls four China A-share-listed subsidiaries — 中直股份 AVIC Helicopter (600038.SH, 53.6%), 洪都航空 Hongdu Aviation (600316.SH, 43.8%), 中航光电 AVIC Jonhon Optronic (002179.SZ, 36.7%), and 中航机载 AVIC Avionics (600372.SH, 16.5%, controlled) — plus wholly/majority-owned unlisted units in aviation engineering services and helicopter trading. Reported segments for H1 2026: aviation whole-aircraft (trainers, helicopters; RMB8.84bn revenue, −14.5% YoY, hit by tax-incentive normalization), aviation ancillary systems & related (avionics, connectors, flight control — the largest and most profitable segment; RMB24.06bn, +6.5% YoY), and aviation engineering services (RMB4.91bn, +8.1% YoY).

Valuation

Method: AviChina is a profitable operating company, but its economics are dominated by large minority-owned, separately-listed subsidiaries (65% of consolidated book equity belongs to minority shareholders). We therefore triangulate three ways: a consolidated three-scenario DCF (owner-FCF basis, RMB), a sum-of-the-parts cross-check using the actual market value of AviChina's stakes in its four listed subsidiaries, and a peer-multiple comparison — then reconcile where they agree and flag where they don't, per house discipline.

1. Three-Scenario DCF (RMB, WACC 6.65% via CAPM: China 10Y yield 1.68%, beta 0.95, ERP 5.0% + 1.5% country premium, cost of debt 3.5%, 25% target debt weight)

Inputs: TTM revenue RMB89.78bn; net cash RMB7.32bn (debt RMB24.05bn vs cash RMB31.38bn, 30 Jun 2026); minority interest RMB64.65bn at book value; tax rate 20% (blended statutory/preferential estimate); 7.973bn diluted shares. Key caveat: fair value is highly sensitive to the minority-interest assumption — book value likely understates it given rich A-share multiples on the underlying subsidiaries (see SOTP below), which would pull equity value down, not up.

2. Reverse DCF — what HK$3.23 (RMB2.76 equiv.) implies

Holding margins/WACC/terminal growth at base case, the current price implies a flat 0.47% revenue CAGR for 10 years. Holding growth at base case, it implies a flat 6.11% operating margin in perpetuity. Both are at or below our Bear case. The market is pricing AviChina as a company whose growth and margins keep eroding from here — more pessimistic than the actual trend in the (admittedly weak) ancillary-systems segment, which is still growing high-single-digits.

3. Sum-of-the-Parts Cross-Check (AviChina's proportional stake, at market, in its own listed subsidiaries)

Per share: RMB8.69 (HK$10.17) unadjusted — nearly 3x AviChina's own RMB22.0bn market cap, using just four of its holdings plus net cash. A-share "pure-play" aerospace/defense names trade at persistently rich, sentiment-driven multiples in the mainland market (35–80x P/E; see peer table), so we apply a 35–40% haircut for cross-market structural discount (capital-mobility/SASAC approval frictions, no clean mechanism for AviChina to monetize these stakes at market, and multiple-compression risk in the richly-valued subsidiaries) → SOTP-adjusted fair value RMB5.2–5.6/share (HK$6.1–6.6). This excludes AviChina's wholly/majority-owned unlisted businesses (engineering services, helicopter trading), which only add to the floor.

4. Peer Table (median-anchored)

AviChina trades at a −67% discount to peer median P/E and a −81% discount to peer median P/B. Some discount is warranted — AviChina's consolidated net margin (~2%) and ROE (~5%) are structurally lower than its higher-margin, pure-play listed subsidiaries, and HK-listed holdcos of A-share stakes almost always trade below the sum of those stakes. But a gap this large, confirmed independently by the DCF and SOTP, is hard to justify on fundamentals alone — this reads as a cross-market/structural mispricing, not a quality-adjusted fair discount. Peer set is mainland A-share dominated given the lack of comparable pure-play HK-listed aerospace/defense industrials; cross-market (A vs H) comparability is a known limitation and is the same effect driving the SOTP discount above.

Conclusion

The insider signal here is genuine and well-documented: New China Life Insurance built a verified, staged open-market position (5.17% → 6.01% in one week, ~HK$145m deployed) in a company whose H1 2026 financials are current (released 26 Aug 2026, five weeks before this report — no data-staleness concerns). Three independent methods — DCF, reverse-DCF, and a stake-by-stake SOTP using real market prices of AviChina's own listed subsidiaries — all point the same direction: the market is pricing AviChina for stagnation and margin erosion worse than even our Bear case, while its underlying stakes in four listed units alone are worth roughly 3x its own market cap before any haircut. After a conservative 35–40% structural/cross-market haircut, fair value still lands at HK$6.00–7.50 against a price of HK$3.23 (30 Sep 2026) — roughly 90–130% upside at the extremes, ~100%+ at the midpoint. Rating: Moderate Buy — not a higher conviction call because of real margin deterioration (net profit −19.3% FY25, −20.1% H1 26), a persistent and possibly structural H-share holdco discount with no clear re-rating catalyst, and sector-specific risks below.

Key Risks

• Margin deterioration is real, not just a sentiment effect: net profit attributable to owners fell 19.3% in FY2025 and a further 20.1% YoY in H1 2026, driven partly by normalization of preferential tax treatment hitting the whole-aircraft/helicopter segment.
• Minority-interest/holdco complexity: ~65% of consolidated book equity belongs to minority shareholders of listed subsidiaries. True look-through value to AviChina's own H-shareholders is genuinely hard to pin down — this report's DCF uses book-value minority interest (likely understating the true claim, biasing the DCF fair value upward) while the SOTP uses market-value stakes (a more real-world check but dependent on volatile A-share multiples).
• The H-share-to-A-share discount may be structural and persistent: capital mobility controls, no mechanism for AviChina to monetize its subsidiary stakes at market value, and a different (HK/international) investor base mean "cheap vs. SOTP" does not imply a timed re-rating catalyst.
• A-share subsidiary multiples are rich and theme-driven (35x–80x P/E, 1.7x–5.2x P/B) — a sentiment reversal in China's domestic defense/aerospace trade would shrink the SOTP floor used here.
• Geopolitical/sanctions exposure: AviChina is a PRC state-owned, defense-adjacent aerospace conglomerate (AVIC Group, ~57–60% owner, is subject to various Western restrictions). Many institutional mandates structurally exclude ownership, capping the realistic buyer base regardless of valuation.
• Buyer's stake is still modest (6.01%) — below levels that would trigger mandatory offer or board-representation dynamics; further accumulation (or a stall) is itself a signal worth monitoring.
• Peer-set and FX limitations: several peer multiples span a wide range across data sources (TTM vs. latest-quarter annualized distortions, especially for earnings-trough Hongdu Aviation); RMB/HKD FX (1 CNY ≈ 1.17 HKD, 30 Sep 2026) and one subsidiary market cap (AVIC Jonhon, dated to late Sept/early Oct 2026, exact day uncertain) introduce minor imprecision that does not change the direction of the conclusion.